Commentary on Cochrane review of neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
- 1 March 2015
- journal article
- review article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 21 (3), 217-221
- https://doi.org/10.1016/j.cmi.2014.10.011
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Financial Conflicts of Interest and Conclusions About Neuraminidase Inhibitors for InfluenzaAnnals of Internal Medicine, 2014
- Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reportsBMJ Open, 2013
- Industry sponsorship and research outcomePublished by Wiley ,2012
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenPublished by Wiley ,2012
- Physical interventions to interrupt or reduce the spread of respiratory virusesCochrane Database of Systematic Reviews, 2011
- Complications: tracking down the data on oseltamivirBMJ, 2009
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisBMJ, 2009
- Time for case-control studies of NSAIDs and oseltamivirBMJ, 2009
- Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and HospitalizationsArchives of Internal Medicine, 2003
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ, 2003